Abstract

An injectable formulation is disclosed for delivery of osteogenic proteins. The formulation comprises a pharmaceutically acceptable admixture of an osteogenic protein; and formulations comprising osteogenic protein, hyaluronic acid derivatives and tricalcium phosphate are also disclosed. Methods for formulating porous injectable gels and pastes from hyaluronic acid are also disclosed.


Claims
Download PDF
Document Preview
Document History
  • Publication: Mar 13, 2007
  • Application: Oct 13, 2000
    US US 68728100 A
  • Priority: Oct 13, 2000
    US US 68728100 A
  • Priority: Feb 28, 2000
    US US 18558700 P
  • Priority: Oct 15, 1999
    US US 15967499 P

Sign in to the Lens